Nội dung được dịch bởi AI, chỉ mang tính chất tham khảo
Rối loạn chức năng tuyến giáp sau khi tiêm vắc xin COVID-19: một đánh giá cơ bản về các bằng chứng sơ bộ
Tóm tắt
Độ an toàn và hiệu quả của một số loại vắc xin COVID-19, bao gồm vắc xin dựa trên mRNA, vắc xin vector virus và vắc xin bất hoạt, đã được Tổ chức Y tế Thế giới (WHO) phê duyệt. Các vắc xin này có thể cung cấp khả năng bảo vệ chống lại nhiễm SARS-CoV-2 nghiêm trọng thông qua việc kích thích sản sinh kháng thể trung hòa chống protein gai. Tuy nhiên, các vắc xin SARS-CoV-2 đã được liên kết với những biến chứng rất hiếm gặp, chẳng hạn như rối loạn tuyến giáp. Bài tổng quan này được thực hiện nhằm làm nổi bật các đặc điểm chính của những bất thường tuyến giáp sau khi tiêm chủng COVID-19. Một tìm kiếm toàn diện trong các cơ sở dữ liệu điện tử đã được tiến hành để thu thập báo cáo về các rối loạn tuyến giáp sau khi tiêm vắc xin COVID-19. Trong số 83 trường hợp được báo cáo trong bài tổng quan này, hầu hết các trường hợp bất thường tuyến giáp được quan sát sau khi tiêm vắc xin dựa trên mRNA (68,7%), tiếp theo là vắc xin vector virus (15,7%) và 14,5% trường hợp sau khi tiêm vắc xin bất hoạt. Viêm tuyến giáp bán cấp (SAT) là bệnh lý tuyến giáp liên quan đến tiêm vắc xin COVID-19 phổ biến nhất, chiếm 60,2% tổng số trường hợp, tiếp theo là bệnh Graves (GD) với 25,3%. Hơn nữa, một số trường hợp viêm tuyến giáp đau khu vực (3,6%), viêm tuyến giáp yên lặng (3,6%), viêm tuyến giáp đồng thời GD và SAT (2,4%), bệnh mắt tuyến giáp (1,2%), suy giáp rõ rệt (1,2%), viêm tuyến giáp bán cấp không điển hình (1,2%) và viêm tuyến giáp không đau kèm theo TPP (1,2%) cũng đã được báo cáo. Tổng thể, trong 58,0% trường hợp SAT và 61,9% trường hợp GD, sự khởi phát của triệu chứng xảy ra sau liều vắc xin đầu tiên với thời gian trung vị là 10,0 ngày (khoảng: 3–21 ngày) và 10,0 ngày (khoảng: 1–60 ngày) sau khi tiêm, tương ứng. Hơn nữa, 40,0% bệnh nhân SAT và 38,1% bệnh nhân GD phát triển triệu chứng sau liều thứ hai với thời gian trung vị là 10,5 ngày (khoảng: 0,5–37 ngày) và 14,0 ngày (khoảng: 2–35 ngày) sau khi tiêm, tương ứng. May mắn thay, hầu hết các trường hợp rối loạn chức năng tuyến giáp liên quan đến tiêm chủng COVID-19 đều có kết quả tích cực sau điều trị. Lợi ích của tiêm vắc xin COVID-19 trong việc chấm dứt đại dịch và/hoặc giảm tỷ lệ tử vong có thể vượt xa bất kỳ rủi ro nào do những biến chứng hiếm gặp như rối loạn chức năng tuyến giáp tạm thời.
Từ khóa
#COVID-19 #vắc xin #rối loạn tuyến giáp #viêm tuyến giáp bán cấp #bệnh GravesTài liệu tham khảo
World Health Organization (2022) WHO COVID-19 dashboard. https://covid19.who.int/
Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K (2021) Cardiovascular complications of SARS-CoV-2 vaccines: an overview. Cardiol Therapy. https://doi.org/10.1007/s40119-021-00248-0
World Health Association. COVID-19 vaccines advice. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice Accessed 18 Dec 2021.
Kyriakidis NC, López-Cortés A, González EV, Grimaldos AB, Prado EO (2021) SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. NPJ Vaccines 6(1):28–28. https://doi.org/10.1038/s41541-021-00292-w
Olivieri B, Betterle C, Zanoni G (2021) Vaccinations and autoimmune diseases. Vaccines 9(8):815. https://doi.org/10.3390/vaccines9080815
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603–2615. https://doi.org/10.1056/NEJMoa2034577
Lim HX, Arip M, Yahaya AAA-F, Jazayeri SD, Poppema S, Poh CL (2021) Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials. Front Biosci 26(11):1286–1304. https://doi.org/10.52586/5024
Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE (2018) Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 14(5):301–316. https://doi.org/10.1038/nrendo.2018.18
Jafarzadeh A, Poorgholami M, Izadi N, Nemati M, Rezayati M (2010) Immunological and hematological changes in patients with hyperthyroidism or hypothyroidism. Clin Invest Med 33(5):E271–E279. https://doi.org/10.25011/cim.v33i5.14352
Bargiel P, Szczuko M, Stachowska L, Prowans P, Czapla N, Markowska M, Petriczko J, Kledzik J, Jędrzejczyk-Kledzik A, Palma J et al (2021) Microbiome metabolites and thyroid dysfunction. J Clin Med 10(16):3609. https://doi.org/10.3390/jcm10163609
Aemaz Ur Rehman M, Farooq H, Ali MM, Ebaad Ur Rehman M, Dar QA, Hussain A (2021) The association of subacute thyroiditis with COVID-19: a systematic review. SN Compr Clin Med. https://doi.org/10.1007/s42399-021-00912-5
Stasiak M, Lewiński A (2021) New aspects in the pathogenesis and management of subacute thyroiditis. Rev Endocr Metab Disord 22(4):1027–1039. https://doi.org/10.1007/s11154-021-09648-y
Ohsako N, Tamai H, Sudo T, Mukuta T, Tanaka H, Kuma K, Kimura A, Sasazuki T (1995) Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab 80(12):3653–3656. https://doi.org/10.1210/jcem.80.12.8530615
Stasiak M, Tymoniuk B, Michalak R, Stasiak B, Kowalski ML, Lewiński A (2020) Subacute thyroiditis is associated with HLA-B*18:01, -DRB1*01 and -C*04:01-the significance of the new molecular background. J Clin Med 9(2):534. https://doi.org/10.3390/jcm9020534
Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ (2003) Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 88(5):2100–2105. https://doi.org/10.1210/jc.2002-021799
Al-Tikrity MA, Magdi M, Abou Samra AB, Elzouki AY (2020) Subacute thyroiditis: an unusual presentation of fever of unknown origin following upper respiratory tract infection. Am J Case Rep 21:e920515. https://doi.org/10.12659/ajcr.920515
Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P (2020) Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord 22(4):803–815. https://doi.org/10.1007/s11154-020-09615-z
Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348(26):2646–2655. https://doi.org/10.1056/NEJMra021194
Patel KR, Cunnane ME, Deschler DG (2021) SARS-CoV-2 vaccine-induced subacute thyroiditis. Am J Otolaryngol 43(1):103211. https://doi.org/10.1016/j.amjoto.2021.103211
Görges J, Ulrich J, Keck C, Müller-Wieland D, Diederich S, Janssen OE (2020) Long-term outcome of subacute thyroiditis. Exp Clin Endocrinol Diabetes 128(11):703–708. https://doi.org/10.1055/a-0998-8035
Samuels MH (2012) Subacute, silent, and postpartum thyroiditis. Med Clin North Am 96(2):223–233. https://doi.org/10.1016/j.mcna.2012.01.003
Li JH, Daniels GH, Barbesino G (2021) Painful subacute thyroiditis is commonly misdiagnosed as suspicious thyroid nodular disease. Mayo Clinic Proc Innov Qual Outcomes 5(2):330–337. https://doi.org/10.1016/j.mayocpiqo.2020.12.007
Cappelli C, Pirola I, Gandossi E, Formenti AM, Agosti B, Castellano M (2014) Ultrasound findings of subacute thyroiditis: a single institution retrospective review. Acta Radiol 55(4):429–433. https://doi.org/10.1177/0284185113498721
Vural Ç, Paksoy N, Gök ND, Yazal K (2015) Subacute granulomatous (De Quervain’s) thyroiditis: fine-needle aspiration cytology and ultrasonographic characteristics of 21 cases. Cytojournal 12:9. https://doi.org/10.4103/1742-6413.157479
Bornemann C, Woyk K, Bouter C (2021) Case report: two cases of subacute thyroiditis following SARS-CoV-2 vaccination. Front Med 8:737142. https://doi.org/10.3389/fmed.2021.737142
Plaza-Enriquez L, Khatiwada P, Sanchez-Valenzuela M, Sikha A (2021) A case report of subacute thyroiditis following mRNA COVID-19 vaccine. Case Rep Endocrinol 2021:8952048. https://doi.org/10.1155/2021/8952048
Siolos A, Gartzonika K, Tigas S (2021) Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature. Metabol Open 12:100136. https://doi.org/10.1016/j.metop.2021.100136
Pujol A, Gómez LA, Gallegos C, Nicolau J, Sanchís P, González-Freire M, López-González ÁA, Dotres K, Masmiquel L (2021) Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves’ disease to silent thyroiditis. J Endocrinol Invest. https://doi.org/10.1007/s40618-021-01707-0
Chatzi S, Karampela A, Spiliopoulou C, Boutzios G (2021) Subacute thyroiditis after SARS-CoV-2 vaccination: a report of two sisters and summary of the literature. Hormones 21(1):177–179. https://doi.org/10.1007/s42000-021-00332-z
Şahin Tekin M, Şaylısoy S, Yorulmaz G (2021) Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccin Immunother 17(11):4090–4092. https://doi.org/10.1080/21645515.2021.1947102
Oyibo SO (2021) Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19). Cureus 13:e16045. https://doi.org/10.7759/cureus.16045
İremli BG, Şendur SN, Ünlütürk U (2021) Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA Syndrome. J Clin Endocrinol Metab 106(9):2600–2605. https://doi.org/10.1210/clinem/dgab373
Franquemont S, Galvez J (2021) Subacute thyroiditis after mRNA vaccine for Covid-19. J Endocr Soc 5:A956–A957. https://doi.org/10.1210/jendso/bvab048.1954
Jeeyavudeen MS, Patrick AW, Gibb FW, Dover AR (2021) COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain’s thyroiditis. BMJ Case Rep 14(11):e246425. https://doi.org/10.1136/bcr-2021-246425
Kyriacou A, Ioakim S, Syed AA (2021) COVID-19 vaccination and a severe pain in the neck. Eur J Intern Med 94:95–96. https://doi.org/10.1016/j.ejim.2021.10.008
Saygılı ES, Karakilic E (2021) Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Reports 14:e244711. https://doi.org/10.1136/bcr-2021-244711
Soltanpoor P, Norouzi G (2021) Subacute thyroiditis following COVID-19 vaccination. Clin Case Rep 9:e04812. https://doi.org/10.1002/ccr3.4812
Schimmel J, Alba EL, Chen A, Russell M, Srinath R (2021) Letter to the editor: thyroiditis and thyrotoxicosis after the SARS-CoV-2 mRNA vaccine. Thyroid 31(9):1440. https://doi.org/10.1089/thy.2021.0184
Ratnayake GM, Dworakowska D, Grossman AB (2021) Can COVID-19 immunisation cause subacute thyroiditis? Clin Endocrinol. https://doi.org/10.1111/cen.14555.10.1111/cen.14555
Lee KA, Kim YJ, Jin HY (2021) Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine 74(3):470–472. https://doi.org/10.1007/s12020-021-02898-5
Khan F, Brassill MJ (2021) Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19. Endocrinol Diabetes Metab Case Rep 2021:21–0142. https://doi.org/10.1530/edm-21-0142
Leber HM, Sant’Ana L, Konichi da Silva NR, Raio MC, Mazzeo T, Endo CM, Nascimento H, de Souza CE (2021) Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: a case report. Ocul Immunol Inflamm 29(6):1200–1206. https://doi.org/10.1080/09273948.2021.1961815
Sözen M, Topaloğlu Ö, Çetinarslan B, Selek A, Cantürk Z, Gezer E, Köksalan D, Bayraktaroğlu T (2021) COVID-19 mRNA vaccine may trigger subacute thyroiditis. Hum Vaccin Immunother 17(12):5120–5125. https://doi.org/10.1080/21645515.2021.2013083
Pandya M, Thota G, Wang X, Luo H (2021) Thyroiditis after coronavirus disease 2019 (COVID-19) mRNA vaccine: a case series. AACE Clin Case Rep. https://doi.org/10.1016/j.aace.2021.12.002
Pla Peris B, Merchante Alfaro AÁ, Maravall Royo FJ, Abellán Galiana P, Pérez Naranjo S, González Boillos M (2022) Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion. J Endocrinol Invest. https://doi.org/10.1007/s40618-022-01739-0
Bostan H, Unsal IO, Kizilgul M, Gul U, Sencar ME, Ucan B, Cakal E (2022) Two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination. Arch Endocrinol Metab. https://doi.org/10.20945/2359-3997000000430
Jhon M, Lee SH, Oh TH, Kang HC (2022) Subacute thyroiditis after receiving the mRNA COVID-19 vaccine (Moderna): the first case report and literature review in Korea. J Korean Med Sci 37:e39. https://doi.org/10.3346/jkms.2022.37.e39
Vasileiou V, Paschou SA, Tzamali X, Mitropoulou M, Kanouta F, Psaltopoulou T, Kassi GN (2022) Recurring subacute thyroiditis after SARS-CoV-2 mRNA vaccine: A case report. Case Rep Womens Health 33:e00378. https://doi.org/10.1016/j.crwh.2021.e00378
Yorulmaz G, Sahin Tekin M (2022) SARS-CoV-2 vaccıne-assocıated subacute thyroıdıtıs. J Endocrinol Invest. https://doi.org/10.1007/s40618-022-01767-w
Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, Eckstein AK, Stagnaro-Green A, Kahaly GJ (2020) Graves’ disease. Nat Rev Dis Primers 6:52. https://doi.org/10.1038/s41572-020-0184-y
Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, Patrizio A, Giusti C, Gonnella D, Cristaudo A et al (2020) Graves’ disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab 34(1):101387. https://doi.org/10.1016/j.beem.2020.101387
Fröhlich E, Wahl R (2017) Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol 8:521–521. https://doi.org/10.3389/fimmu.2017.00521
Murugan AK, Alzahrani AS (2021) SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease. Endocrine 73(2):243–254. https://doi.org/10.1007/s12020-021-02770-6
Mehraji Z, Farazmand A, Esteghamati A, Noshad S, Sadr M, Amirzargar S, Yekaninejad MS, Amirzargar A (2017) Association of human leukocyte antigens class I and II with Graves’ Disease in Iranian population. Iran J Immunol 14(3):223–230
Zettinig G, Krebs M (2021) Two further cases of Graves’ disease following SARS-Cov-2 vaccination. J Endocrinol Invest 45(1):227–228. https://doi.org/10.1007/s40618-021-01650-0
Raven LM, McCormack AI, Greenfield JR (2021) Letter to the editor from Raven: three cases of Subacute Thyroiditis following SARS-CoV-2 vaccine. J Clin Endocrinol Metab 106(9):2600–2605. https://doi.org/10.1210/clinem/dgab822
Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sánchez Valadez TI, Jara LJ (2021) Two cases of Graves’ Disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid 31(9):1436–1439. https://doi.org/10.1089/thy.2021.0142
Lui DTW, Lee KK, Lee CH, Lee ACH, Hung IFN, Tan KCB (2021) Development of Graves’ Disease after SARS-CoV-2 mRNA vaccination: a case report and literature review. Front Public Health 9:778964. https://doi.org/10.3389/fpubh.2021.778964
Weintraub MA, Ameer B, Sinha Gregory N (2021) Graves Disease following the SARS-CoV-2 vaccine: case series. J Investig Med High Impact Case Rep 9:23247096211063356. https://doi.org/10.1177/23247096211063356
Sriphrapradang C, Shantavasinkul PC (2021) Graves’ disease following SARS-CoV-2 vaccination. Endocrine 74(3):473–474. https://doi.org/10.1007/s12020-021-02902-y
Patrizio A, Ferrari SM, Antonelli A, Fallahi P (2021) A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun 125:102738. https://doi.org/10.1016/j.jaut.2021.102738
Pierman G, Delgrange E, Jonas C (2021) Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) following SARS-CoV-2 mRNA vaccine administration: a simple coincidence? Eur J Case Rep Intern Med 8(9):002807–002807. https://doi.org/10.12890/2021_002807
Goblirsch TJ, Paulson AE, Tashko G, Mekonnen AJ (2021) Graves’ disease following administration of second dose of SARS-CoV-2 vaccine. BMJ Case Rep 14(12):e246432. https://doi.org/10.1136/bcr-2021-246432
Sakiyama R (1986) Silent thyroiditis. J Fam Pract 23:367–369
McAlinden C (2014) An overview of thyroid eye disease. Eye Vis 1:9–9. https://doi.org/10.1186/s40662-014-0009-8
Lazarus JH (2012) Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab 26(3):273–279. https://doi.org/10.1016/j.beem.2011.10.005
Łacheta D, Miśkiewicz P, Głuszko A, Nowicka G, Struga M, Kantor I, Poślednik KB, Mirza S, Szczepański MJ (2019) Immunological aspects of Graves’ ophthalmopathy. Biomed Res Int 2019:7453260–7453260. https://doi.org/10.1155/2019/7453260
Rubinstein TJ (2021) Thyroid eye disease following COVID-19 vaccine in a patient with a history Graves’ Disease: a case report. Ophthalmic Plast Reconstr Surg 37(6):e221–e223. https://doi.org/10.1097/iop.0000000000002059
Capezzone M, Tosti-Balducci M, Morabito EM, Caldarelli GP, Sagnella A, Cantara S, Alessandri M, Castagna MG (2022) Silent thyroiditis following vaccination against COVID-19: report of two cases. J Endocrinol Invest. https://doi.org/10.1007/s40618-021-01725-y
Nakaizumi N, Fukata S, Akamizu T (2022) Painless thyroiditis following mRNA vaccination for COVID-19. Hormones. https://doi.org/10.1007/s42000-021-00346-7
Giusti M, Maio A (2021) Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination. Clin Case Rep 9:e05217. https://doi.org/10.1002/ccr3.5217
Hernán Martinez J, Corder E, Uzcategui M, Garcia M, Sostre S, Garcia A (2011) Subacute thyroiditis and dyserythropoesis after influenza vaccination suggesting immune dysregulation. Bol Asoc Med P R 103(2):48–52
Girgis CM, Russo RR, Benson K (2010) Subacute thyroiditis following the H1N1 vaccine. J Endocrinol Invest 33(7):506. https://doi.org/10.1007/bf03346633
Altay FA, Güz G, Altay M (2016) Subacute thyroiditis following seasonal influenza vaccination. Hum Vaccin Immunother 12(4):1033–1034. https://doi.org/10.1080/21645515.2015.1117716
Passah A, Arora S, Damle NA, Reddy KS, Khandelwal D, Aggarwal S (2018) Occurrence of Subacute Thyroiditis following influenza vaccination. Indian J Endocrinol Metab 22(5):713–714. https://doi.org/10.4103/ijem.IJEM_237_18
Pellegrino P, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, Radice S (2015) The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res 61(1–2):90–96. https://doi.org/10.1007/s12026-014-8567-3
Xie Q, Mu XY, Li SQ (2021) Subacute thyroiditis following HPV vaccination: a case report. Sichuan Da Xue Xue Bao Yi Xue Ban 52(6):1047–1048. https://doi.org/10.12182/20211160506
Toft J, Larsen S, Toft H (1998) Subacute thyroiditis after hepatitis B vaccination. Endocr J 45(1):135
Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y (2020) ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab 34(1):101412. https://doi.org/10.1016/j.beem.2020.101412
Murugan AK, Alzahrani AS (2021) SARS-CoV-2: emerging role in the pathogenesis of various thyroid diseases. J Inflamm Res 14:6191–6221. https://doi.org/10.2147/jir.s332705
Giovanella L, Ruggeri RM, Ovčariček PP, Campenni A, Treglia G, Deandreis D (2021) Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. https://doi.org/10.1007/s40336-021-00419-y
Vojdani A, Vojdani E, Kharrazian D (2020) Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol 11:617089. https://doi.org/10.3389/fimmu.2020.617089
Vojdani A, Kharrazian D (2020) Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 217:108480. https://doi.org/10.1016/j.clim.2020.108480
Jadali Z (2020) COVID- 19 and thyroid infection: learning the lessons of the past. Acta Endocrinol 16(3):375–376. https://doi.org/10.4183/aeb.2020.375
Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT (1998) Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281(5377):703–706. https://doi.org/10.1126/science.281.5377.703
Vadalà M, Poddighe D, Laurino C, Palmieri B (2017) Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? EPMA J 8(3):295–311. https://doi.org/10.1007/s13167-017-0101-y
Chen RT, Pless R, Destefano F (2001) Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 16(3):309–318. https://doi.org/10.1006/jaut.2000.0491
Yazdanpanah N, Rezaei N (2022) Autoimmune complications of COVID-19. J Med Virol 94(1):54–62. https://doi.org/10.1002/jmv.27292
Safdari V, Alijani E, Nemati M, Jafarzadeh A (2017) Imbalances in T cell-related transcription factors among patients with Hashimoto’s Thyroiditis. Sultan Qaboos Univ Med J 17(2):e174–e180. https://doi.org/10.18295/squmj.2016.17.02.007
Janyga S, Marek B, Kajdaniuk D, Ogrodowczyk-Bobik M, Urbanek A, Bułdak Ł (2021) CD4+ cells in autoimmune thyroid disease. Endokrynol Pol 72(5):572–583. https://doi.org/10.5603/EP.a2021.0076
Teijaro JR, Farber DL (2021) COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol 21(4):195–197. https://doi.org/10.1038/s41577-021-00526-x
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M (2020) Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci 257:118102. https://doi.org/10.1016/j.lfs.2020.118102
Zhang C, Maruggi G, Shan H, Li J (2019) Advances in mRNA vaccines for infectious diseases. Front Immunol 10:594. https://doi.org/10.3389/fimmu.2019.00594
Singh RP, Bischoff DS (2021) Sex hormones and gender influence the expression of markers of regulatory T cells in SLE patients. Front Immunol 12:619268. https://doi.org/10.3389/fimmu.2021.619268
Tu Y, Fan G, Zeng T, Cai X, Kong W (2018) Association of TNF-α promoter polymorphism and Graves’ disease: an updated systematic review and meta-analysis. Biosci Rep 38:BSR20180143. https://doi.org/10.1042/BSR20180143
Davarpanah E, Jafarzadeh A, Nemati M, Bassagh A, Abasi MH, Khosravimashizi A, Kazemipoor N, Ghazizadeh M, Mirzaee M (2020) Circulating concentration of interleukin-37 in Helicobacter pylori-infected patients with peptic ulcer: Its association with IL-37 related gene polymorphisms and bacterial virulence factor CagA. Cytokine 126:154928. https://doi.org/10.1016/j.cyto.2019.154928
Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, Hasell J, Macdonald B, Beltekian D, Roser M (2020) "Coronavirus Pandemic (COVID-19)". Published online at OurWorldInData.org. 'https://ourworldindata.org/coronavirus'.